TY  - RPRT
TI  - Immunotherapy of CT26 murine tumors is characterized by an oligoclonal response against the AH1 tumor rejection antigen
AU  - Probst, P.
AU  - Stringhini, M.
AU  - Neri, D.
PY  - 2019
DO  - 10.1101/789784
UR  - https://www.biorxiv.org/content/10.1101/789784v1
ID  - 10.1101/789784
ER  -